DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Berdelou A, Borget I, Godbert Y. et al.
Lenvatinib for the treatment of radioiodine-refractory.
thyroid cancer in real-life practice. Thyroid 2018;
28: 72-78
Access:
We do not assume any responsibility for the contents of the web pages of other providers.